Shah, R., Sabir, S., & Alhawaj, A
You can find more information on our GHK-Cu 100mg product page
Disclosure Fernando Gomez-Peralta has received research support from Sanofi, Novo Nordisk, Boehringer Ingelheim, and Eli Lilly, has taken part in advisory boards for Sanofi, Novo Nordisk, and AstraZeneca Pharmaceuticals LP, and has acted as a speaker for Sanofi, Novo Nordisk, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb Company, Eli Lilly, and AstraZeneca Pharmaceuticals LP
Effective lobbying takes time, energy, expertise, support things that small charities and patients with Pernicious Anaemia and B12 deficiency dont have in abundance
By starting at a fraction of the standard dose, your body can adapt to the medication more gradually